"Although arteriovenous malformations are thought to represent a congenital abnormality, they are rarely found incidentally in the very young, and many de novo lesions have been described amongst adults17. They are thought to expand over time. Despite this, a third of arteriovenous malformations that are diagnosed due to haemorrhage are identified before the age of 20 years 7. Overall, they are diagnosed at a mean age of 31 years 8."
"Arteriovenous malformations are thought to occur in approximately 0.05% of the population16. There is no gender predilection 8."
"compact (or glomerular) nidus: abnormal vessels without any interposed normal brain tissue. More common than diffuse nidus type"
"diffuse (or proliferative) nidus: no well-formed nidus is present, with functional neuronal tissue interspersed amongst the anomalous vessels"
"T2: shows a tangle of flow voids"
"T2*/SWI: might show haemosiderin deposits as an indicator of prior haemorrhage"
"This article corresponds to the classic form of arteriovenous malformation involving the brain parenchyma. The term brain arteriovenous malformation (BAVM) is the preferred term 12. An alternative is cerebral arteriovenous malformation (CAVM), but the term cerebral leaves out more caudal brain structures and the abbreviation could be confused with cavernous malformation. It is also referred to as a pial arteriovenous malformation if it is related to the pial vessels, but this is not always the case 6."
"This article corresponds to the classic form of arteriovenous malformation involving the brain parenchyma. The term brain arteriovenous malformation (BAVM) is the preferred term 12. An alternative is cerebral arteriovenous malformation (CAVM), but the term cerebral leaves out more caudal brain structures and the abbreviation could be confused with cavernous malformation. It is also referred to as a pial arteriovenous malformation if it is related to the pial vessels, but this is not always the case 6."
"Although arteriovenous malformations are thought to represent a congenital abnormality, they are rarely found incidentally in the very young, and many de novo lesions have been described amongst adults17. They are thought to expand over time. Despite this, a third of arteriovenous malformations that are diagnosed due to haemorrhage are identified before the age of 20 years 7. Overall, they are diagnosed at a mean age of 31 years 8."
"MAP2K1 (Mitogen-activated protein kinase kinase 1)"
"PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)"
"ACVRL1 (activin receptor-like kinase 1)"
"ENG (endoglin)"
"SMAD4 (Mothers against decapentaplegic homolog 4)"
"The Spetzler-Martin AVM grading system relates morphology and location to the risk of surgery."
"Numerous genes have been implicated in the pathogenesis of arteriovenous malformations, including overexpression of VEGF (vascular endothelial growth factor) and dysregulation of RAS/MAPK, NOTCH, and TGF-β signalling pathways 19. The interplay between these is complex and varies depending on the clinical syndrome, with some notable examples including 19:"
"Numerous genes have been implicated in the pathogenesis of arteriovenous malformations, including overexpression of VEGF (vascular endothelial growth factor) and dysregulation of RAS/MAPK, NOTCH, and TGF-β signalling pathways 19. The interplay between these is complex and varies depending on the clinical syndrome, with some notable examples including 19:"
"Numerous genes have been implicated in the pathogenesis of arteriovenous malformations, including overexpression of VEGF (vascular endothelial growth factor) and dysregulation of RAS/MAPK, NOTCH, and TGF-β signalling pathways 19. The interplay between these is complex and varies depending on the clinical syndrome, with some notable examples including 19:"
"association with facial AVM"
"MAP2K1 (Mitogen-activated protein kinase kinase 1)"
"Although rarely, arteriovenous malformations have been known to spontaneously resolve 20-22, the vast majority do not, and therefore they require consideration of treatment, as the annual risk of haemorrhage for an unruptured arteriovenous malformation is ~1.4% per year 18, resulting from a flow-related aneurysm, intra-nidal aneurysm, or venous thrombosis (rarely)."
Expected headings
"Incidence"
"Associated abnormalities"
"Classification and grading"
"Signal characteristics"
"Arteriovenous malformations are thought to occur in approximately 0.05% of the population16. There is no gender predilection 8."
"The exact origin of arteriovenous malformations remains uncertain. Although they are thought to be congenital, many contributing factors, including genetics (see below), haemodynamic factors, and inflammation, result in them being dynamic lesions 3,19."
"Although rarely, arteriovenous malformations have been known to spontaneously resolve 20-22, the vast majority do not, and therefore they require consideration of treatment, as the annual risk of haemorrhage for an unruptured arteriovenous malformation is ~1.4% per year 18, resulting from a flow-related aneurysm, intra-nidal aneurysm, or venous thrombosis (rarely)."
"Radiological evidence of previous haemorrhage is the most important predictor of future haemorrhage; it is therefore important to distinguish AVMs that have bled from those that have not bled 6."
"Counter-intuitively, smaller arteriovenous malformations (≤3 cm) are at greater risk of haemorrhage due to the higher pressure of the feeding artery 14. In paediatric patients, presentation with rupture correlates with specific morphological and anatomical traits, other than smaller nidus dimensions; these include deep or infratentorial positioning, diffuse morphology, and deep venous drainage 23. Following haemorrhage, the risk of a further bleed in the next 12 months is up to 18% 5."
"Angioarchitectural weak points due to intranidal aneurysm, ectasia or stenosis of draining veins, single draining vein or deep draining vein, or deep or posterior fossa location of the arteriovenous malformation are associated with a high risk of future haemorrhage and also need to be commented on 6."
"Risk of non-haemorrhagic complications like focal neurological deficit increases with a high flow shunt, venous congestion or obstruction, a long pial course of a draining vein, arterial steal, mass effect, hydrocephalus and perinidal gliosis 6."
|
No data |